Faculty profile

May Faraj

ResearcherMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.

May Faraj

Researcher

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
3 publications in the last five years, latest in 2024.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2016.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Caspases Inflammasome Inflammation Insulin Resistance Metabolism Obesity

Latest papers

EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors.
Scientific reports · 2024 · senior author
IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease.
Diabetes · 2023
Native low-density lipoproteins are priming signals of the NLRP3 inflammasome/interleukin-1β pathway in human adipose tissue and macrophages.
Scientific reports · 2023 · senior author

All 21 publications

Latest funding

Effects of GLP1-agonist induced weight loss on brain, metabolic, and cerebrovascular health measures.
CIHR · 2024 · Co-investigator
$1,346,400
Effects of GLP1 agonist-induced weight loss on cerebral and blood markers of neurodegeneration in individuals with obesity and genetic risk for Alzheimer's disease.
CIHR · 2024 · Co-investigator
$1,057,080
Genetic and functional analyses of the inflammatory caspases and inflammasomes in obesity, metabolic inflammation and insulin resistance
CIHR · 2016 · Principal investigator
$100,000

All 3 grants and awards

21 publications.

EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors.

Lamantia V, Bissonnette S, Beaudry M, Cyr Y, Rosiers CD, Baass A, Faraj M

Scientific reports2024Senior author

DOI: 10.1038/s41598-024-73672-6 PMID: 39511203

IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease.

Gunes A, Schmitt C, Bilodeau L, Huet C, Belblidia A, Baldwin C, Giard JM, Biertho L, Lafortune A, Couture CY, Cheung A, Nguyen BN, Galun E, Bémeur C, Bilodeau M, Laplante M, Tang A, Faraj M, Estall JL

Diabetes2023

DOI: 10.2337/db23-0171 PMID: 37757741

Native low-density lipoproteins are priming signals of the NLRP3 inflammasome/interleukin-1β pathway in human adipose tissue and macrophages.

Bissonnette S, Lamantia V, Ouimet B, Cyr Y, Devaux M, Rabasa-Lhoret R, Chrétien M, Saleh M, Faraj M

Scientific reports2023Senior author

DOI: 10.1038/s41598-023-45870-1 PMID: 37914804

Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface-expression of LDLR and CD36 and NLRP3 inflammasome.

Cyr Y, Lamantia V, Bissonnette S, Burnette M, Besse-Patin A, Demers A, Wabitsch M, Chrétien M, Mayer G, Estall JL, Saleh M, Faraj M

Physiological reports2021Senior author

DOI: 10.14814/phy2.14721 PMID: 33527668

White Adipose Tissue Surface Expression of LDLR and CD36 is Associated with Risk Factors for Type 2 Diabetes in Adults with Obesity.

Cyr Y, Bissonnette S, Lamantia V, Wassef H, Loizon E, Ngo Sock ET, Vidal H, Mayer G, Chrétien M, Faraj M

Obesity (Silver Spring, Md.)2020Senior author

DOI: 10.1002/oby.22985 PMID: 33043593

LDL, LDL receptors, and PCSK9 as modulators of the risk for type 2 diabetes: a focus on white adipose tissue.

Faraj M

Journal of biomedical research2020First author

DOI: 10.7555/jbr.34.20190124 PMID: 32701068

High plasma apolipoprotein B identifies obese subjects who best ameliorate white adipose tissue dysfunction and glucose-induced hyperinsulinemia after a hypocaloric diet.

Bissonnette S, Saint-Pierre N, Lamantia V, Leroux C, Provost V, Cyr Y, Rabasa-Lhoret R, Faraj M

The American journal of clinical nutrition2018Senior author

DOI: 10.1093/ajcn/nqy070 PMID: 29917037

Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.

Wassef H, Bissonnette S, Dufour R, Davignon J, Faraj M

The Journal of nutrition2017Senior author

DOI: 10.3945/jn.116.242750 PMID: 28356429

ApoB-lipoproteins and dysfunctional white adipose tissue: Relation to risk factors for type 2 diabetes in humans.

Lamantia V, Bissonnette S, Wassef H, Cyr Y, Baass A, Dufour R, Rabasa-Lhoret R, Faraj M

Journal of clinical lipidology2017Senior author

DOI: 10.1016/j.jacl.2016.09.013 PMID: 28391908

WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.

Cyr Y, Wassef H, Bissonnette S, Lamantia V, Davignon J, Faraj M

Journal of lipid research2016Senior author

DOI: 10.1194/jlr.p064170 PMID: 27040450

Something wrong or missing on this profile? Suggest a correction

May Faraj

Research

Latest papers

Latest funding

EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors.

IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease.

Native low-density lipoproteins are priming signals of the NLRP3 inflammasome/interleukin-1β pathway in human adipose tissue and macrophages.

Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface-expression of LDLR and CD36 and NLRP3 inflammasome.

White Adipose Tissue Surface Expression of LDLR and CD36 is Associated with Risk Factors for Type 2 Diabetes in Adults with Obesity.

LDL, LDL receptors, and PCSK9 as modulators of the risk for type 2 diabetes: a focus on white adipose tissue.

High plasma apolipoprotein B identifies obese subjects who best ameliorate white adipose tissue dysfunction and glucose-induced hyperinsulinemia after a hypocaloric diet.

Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.

ApoB-lipoproteins and dysfunctional white adipose tissue: Relation to risk factors for type 2 diabetes in humans.

WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.

Effects of GLP1-agonist induced weight loss on brain, metabolic, and cerebrovascular health measures.

Effects of GLP1 agonist-induced weight loss on cerebral and blood markers of neurodegeneration in individuals with obesity and genetic risk for Alzheimer's disease.

Genetic and functional analyses of the inflammatory caspases and inflammasomes in obesity, metabolic inflammation and insulin resistance

Frequent collaborators

May Faraj

Rémi Rabasa-Lhoret

Rémi Rabasa-Lhoret

Maya Saleh

Laurent Biertho

Mathieu Laplante

Marie-Eve Mathieu

An Tang

Denis Prud'homme

Mathieu Laplante

May Faraj

Research

Latest papers

Latest funding

EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1&#x3b2; pathway and its association with diabetes risk factors.

IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease.

Native low-density lipoproteins are priming signals of the NLRP3 inflammasome/interleukin-1&#x3b2; pathway in human adipose tissue and macrophages.

Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface-expression of LDLR and CD36 and NLRP3 inflammasome.

White Adipose Tissue Surface Expression of LDLR and CD36 is Associated with Risk Factors for Type 2 Diabetes in Adults with Obesity.

LDL, LDL receptors, and PCSK9 as modulators of the risk for type 2 diabetes: a focus on white adipose tissue.

High plasma apolipoprotein B identifies obese subjects who best ameliorate white adipose tissue dysfunction and glucose-induced hyperinsulinemia after a hypocaloric diet.

Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.

ApoB-lipoproteins and dysfunctional white adipose tissue: Relation to risk factors for type 2 diabetes in humans.

WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.

Effects of GLP1-agonist induced weight loss on brain, metabolic, and cerebrovascular health measures.

Effects of GLP1 agonist-induced weight loss on cerebral and blood markers of neurodegeneration in individuals with obesity and genetic risk for Alzheimer's disease.

Genetic and functional analyses of the inflammatory caspases and inflammasomes in obesity, metabolic inflammation and insulin resistance

Frequent collaborators

May Faraj

Rémi Rabasa-Lhoret

Rémi Rabasa-Lhoret

Maya Saleh

Laurent Biertho

Mathieu Laplante

Marie-Eve Mathieu

An Tang

Denis Prud'homme

Mathieu Laplante

EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors.

Native low-density lipoproteins are priming signals of the NLRP3 inflammasome/interleukin-1β pathway in human adipose tissue and macrophages.